The Urology Care Devices and Platforms Market was valued at USD 45.57 Billion in 2024 and is expected to grow from USD 49.63 Billion in 2025 to USD 98.39 Billion by 2033, registering a CAGR of 8.93% during the forecast period (2025–2033). The rising prevalence of urological conditions such as urinary tract infections (UTIs), kidney stones, prostate disorders, and urinary incontinence is a major driver of this market. With an aging population and changing lifestyles, the demand for advanced urology care solutions continues to rise.

📥 Download Sample

Market Overview

Urology is a critical medical field dealing with illnesses of the urinary system and male reproductive organs. Devices in this market include endoscopes, dialysis systems, neurostimulators, and robotic platforms, all aimed at improving diagnosis, treatment, and recovery outcomes. Alongside devices, digital platforms for imaging analytics, data management, and remote patient monitoring are reshaping patient care and clinical workflows.

Key Market Highlights

  • Devices dominate the product segment

  • Treatment leads the application segment

  • Hospitals, ambulatory surgery centers, and clinics account for the largest end-user share

  • North America holds the highest market share globally

Growth Drivers

  • Rising prevalence of urinary disorders such as UTIs, kidney diseases, and incontinence

  • Higher risks among diabetic patients and women during pregnancy and menopause

  • Increasing cases of kidney injuries linked to COVID-19 complications

  • Product portfolio expansion through strategic mergers and acquisitions, such as Olympus acquiring Medi-Tate Ltd’s iTind device

Market Restraints

  • High upfront costs of advanced devices, especially single-use endoscopes

  • Increased healthcare expenditure leading to higher treatment costs and reduced affordability

Opportunities Ahead

Emerging regional companies are disrupting the market with AI-driven and machine learning-based solutions, enhancing diagnostics and treatment options. Startups like Axonics Modulation Technologies, Valencia Technologies, and NanoVibronix are expanding competition and offering innovative products for healthcare providers and patients.

Regional Insights

  • North America dominates the global market with a CAGR of 8.44%, supported by rising chronic kidney disease cases and adoption of remote patient monitoring solutions.

  • Europe shows steady growth, driven by local players like B. Braun and Medtronic, alongside increasing prevalence of kidney disease and diabetes.

  • Asia-Pacific is the fastest-growing region, with strong contributions from Olympus, Fujifilm, and local Chinese manufacturers offering cost-effective solutions.

  • Latin America and Middle East & Africa are emerging markets, supported by government initiatives and improving healthcare infrastructure.

Key Players

  • B. Braun Melsungen AG

  • Boston Scientific Corporation

  • Cardinal Health Inc.

  • Axonics Modulation Technologies Inc.

  • Fresenius Medical Care AG & Co. KGaA

  • Intuitive Surgical Inc.

  • Medtronic plc

  • Baxter International Inc.

  • Olympus Corporation

  • Becton, Dickinson and Company

  • Others

Recent Developments

  • April 2024 – I-O Urology received investment from Laborie Medical Technologies to expand CarePath uroflow, an FDA-approved at-home diagnostic tool for urinary tract symptoms.

  • May 2024 – Dornier MedTech launched Urogpt, an AI-powered assistant for kidney stone patients, developed in collaboration with top urologists.

Conclusion

The global urology care devices and platforms market is on a strong growth path, fueled by rising disease prevalence, technological innovation, and wider adoption of AI-powered solutions. While high costs remain a challenge, emerging players and regional advancements are opening new opportunities for market expansion.

About Us:

Straits Research is a leading global market intelligence and consulting firm, dedicated to delivering actionable insights and in-depth analysis across a wide range of industries. Our mission is to empower organizations, investors, and decision-makers with reliable data, strategic guidance, and forward-looking perspectives to help them thrive in a rapidly evolving business landscape.

Contact Us:

Email: sales@straitsresearch.com
Tel: +1 646 905 0080 (U.S.), +44 203 695 0070 (U.K.)
Website: https://straitsresearch.com/